ID
33187
Description
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Mots-clés
Versions (2)
- 05/11/2018 05/11/2018 -
- 30/11/2018 30/11/2018 -
Détendeur de droits
GSK group of companies
Téléchargé le
30 novembre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Non-Serious Adverse Event Form
- StudyEvent: ODM
Similar models
Non-Serious Adverse Event Form
- StudyEvent: ODM
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1705586 (UMLS CUI [1,2])
C0439603 (UMLS CUI [1,2])
C0332162 (UMLS CUI [1,2])
C0332162 (UMLS CUI [1,2])
C0806909 (UMLS CUI [1,2])
C0518690 (UMLS CUI [2,1])
C0806909 (UMLS CUI [2,2])
C0332162 (UMLS CUI [1,2])
C0518690 (UMLS CUI [2,1])
C0332162 (UMLS CUI [2,2])
C0877248 (UMLS CUI [2])
C1518404 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0085978 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C1762893 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])